Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201203004 Principal Investigator: Linette, Gerald
Title: An Open-Label, Single-Arm, Phase II, Multicenter Study To Evaluate The Efficacy of Vemurafenib in Metastatic Melanaoma Patients with Brain Metastases
Phase: II Disease Site: Melanoma, Skin
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to learn more about the safety, side effects and response to treatment of a new drug called vemurafenib in patients who have melanoma skin cancer that has metastasized (spread) to the brain.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)